Latterich Martin 4
4 · Histogen Inc. · Filed May 28, 2020
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Latterich Martin
See Remarks
Transactions
- Other
Common Stock
2020-05-26+11,951→ 11,951 total - Other
Stock Option (right to buy)
2016-10-07+28,684→ 28,684 totalExercise: $3.70Exp: 2026-10-07→ Common Stock (28,684 underlying) - Other
Stock Option (right to buy)
2018-03-12+14,342→ 14,342 totalExercise: $3.84Exp: 2028-03-12→ Common Stock (14,342 underlying)
Footnotes (3)
- [F1]Shares of common stock of the corporation formerly known as Histogen Inc. ("Histogen") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among the Issuer, Chinook Merger Sub, Inc. and Histogen (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Histogen common stock was exchanged for 1.4342 shares of the Issuer's common stock (the "Conversion"). Immediately following the merger, the Issuer changed its name to Histogen Inc. All share numbers reflect the one-for-ten reverse stock split (the "Reverse Split") effected by the Issuer immediately prior to the completion of the merger.
- [F2]Shares subject to the option vest in 48 equal monthly installments. Shares subject to the option and the exercise price have been adjusted based upon the Conversion and Reverse Split.
- [F3]Shares subject to the option vest in 48 equal monthly installments. Shares subject to the option and the exercise price have been adjusted based upon the Conversion and Reverse Split.